SK283279B6 - Orálny farmaceutický prostriedok protihubovo účinnej zlúčeniny a spôsob jeho prípravy - Google Patents

Orálny farmaceutický prostriedok protihubovo účinnej zlúčeniny a spôsob jeho prípravy Download PDF

Info

Publication number
SK283279B6
SK283279B6 SK86-2001A SK862001A SK283279B6 SK 283279 B6 SK283279 B6 SK 283279B6 SK 862001 A SK862001 A SK 862001A SK 283279 B6 SK283279 B6 SK 283279B6
Authority
SK
Slovakia
Prior art keywords
compound
pharmaceutical composition
inert core
oral pharmaceutical
hydrophilic polymer
Prior art date
Application number
SK86-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK862001A3 (en
Inventor
Darder Carlos Picornell
Original Assignee
Liconsa, Liberacion Controlada De Sustancias Activas, S. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8304581&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK283279(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liconsa, Liberacion Controlada De Sustancias Activas, S. A. filed Critical Liconsa, Liberacion Controlada De Sustancias Activas, S. A.
Publication of SK862001A3 publication Critical patent/SK862001A3/sk
Publication of SK283279B6 publication Critical patent/SK283279B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
SK86-2001A 1998-07-21 1999-07-20 Orálny farmaceutický prostriedok protihubovo účinnej zlúčeniny a spôsob jeho prípravy SK283279B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009801539A ES2157731B1 (es) 1998-07-21 1998-07-21 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
PCT/ES1999/000230 WO2000004881A1 (es) 1998-07-21 1999-07-20 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion

Publications (2)

Publication Number Publication Date
SK862001A3 SK862001A3 (en) 2001-08-06
SK283279B6 true SK283279B6 (sk) 2003-05-02

Family

ID=8304581

Family Applications (1)

Application Number Title Priority Date Filing Date
SK86-2001A SK283279B6 (sk) 1998-07-21 1999-07-20 Orálny farmaceutický prostriedok protihubovo účinnej zlúčeniny a spôsob jeho prípravy

Country Status (31)

Country Link
US (1) US6737082B1 (xx)
EP (1) EP1103252B1 (xx)
JP (1) JP4190732B2 (xx)
KR (1) KR100572135B1 (xx)
AT (1) ATE234077T1 (xx)
AU (1) AU750730B2 (xx)
BG (1) BG65187B1 (xx)
BR (1) BR9912300A (xx)
CA (1) CA2337509C (xx)
CZ (1) CZ291938B6 (xx)
DE (1) DE69905905T2 (xx)
DK (1) DK1103252T3 (xx)
EE (1) EE04415B1 (xx)
ES (2) ES2157731B1 (xx)
HK (1) HK1037531A1 (xx)
HR (1) HRP20010128B1 (xx)
HU (1) HU228895B1 (xx)
IL (1) IL140910A (xx)
ME (1) MEP26708A (xx)
MX (1) MXPA01000681A (xx)
NO (1) NO320054B1 (xx)
NZ (1) NZ509886A (xx)
PL (1) PL194740B1 (xx)
PT (1) PT1103252E (xx)
RS (1) RS50063B (xx)
RU (1) RU2209628C2 (xx)
SK (1) SK283279B6 (xx)
TR (1) TR200100177T2 (xx)
UA (1) UA64009C2 (xx)
WO (1) WO2000004881A1 (xx)
ZA (1) ZA200101293B (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT877563E (pt) * 1996-01-31 2004-08-31 Univ South Alabama Preparacoes alimentares e vitaminicas contendo o isomero natural de folatos reduzidos
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
JP2003518485A (ja) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク 向上された薬物濃度を与える医薬組成物
FR2842736B1 (fr) * 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
DK1438961T4 (da) * 2003-01-14 2014-11-17 Acino Pharma Ag Bioækvivalent sammensætning af itraconazol dispergeret i en hydrofil polymer
SI1438960T2 (sl) * 2003-01-14 2013-04-30 Cimex Pharma Ag Sestavek itrakonazola, dispergiranega v hidrofilnem polimeru, z izboljšano biorazpoložljivostjo
FR2852607B1 (fr) * 2003-03-20 2006-07-14 Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications
WO2005011702A1 (en) * 2003-07-17 2005-02-10 Tibotec Pharmaceuticals Ltd. Process for preparing particles containing an antiviral
FR2857591B1 (fr) * 2003-07-17 2007-11-02 Ethypharm Sa Particules comprenant un principe actif sous forme de co-precipite
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
US8653083B2 (en) 2005-08-22 2014-02-18 The Johns Hopkins University Hedgehog pathway antagonists to treat disease
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
JP2013521249A (ja) * 2010-03-05 2013-06-10 ビーエーエスエフ ソシエタス・ヨーロピア 融解物で被覆された医薬形態
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
MA40982A (fr) * 2014-11-19 2017-09-26 Biogen Ma Inc Formulation de bille pharmaceutique comprenant du fumarate de diméthyle
WO2016189481A1 (en) * 2015-05-25 2016-12-01 Sun Pharmaceutical Industries Limited Once daily oral pharmaceutical composition of isotretinoin
CA3033065A1 (en) 2016-08-11 2018-02-15 Adamis Pharmaceuticals Corporation Drug compositions
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy
EP3720844A4 (en) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation MEDICINAL COMPOSITIONS
EP3786231A4 (en) * 2018-04-27 2021-06-09 Toppan Printing Co., Ltd. DELAYED RELEASE COMPOSITE PARTICLES, METHOD FOR MANUFACTURING DELAYED RELEASE COMPOSITE PARTICLES, DRY POWDER AND WALLPAPER
WO2023118082A1 (en) * 2021-12-22 2023-06-29 Palau Pharma, S.L.U. Multiparticulate albaconazole composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4916134A (en) * 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
CA2240161C (en) * 1996-05-20 2005-05-24 Janssen Pharmaceutica N.V. Antifungal compositions with improved bioavailability
TR199802424T2 (xx) * 1996-05-24 1999-03-22 Schering Corporation Biyo-temin-edilebilirli�i artt�r�lm�� mantara-kar�� bile�im.
CN1228693A (zh) * 1996-06-28 1999-09-15 先灵公司 含有三唑类抗真菌化合物的口服组合物
DE19626924C2 (de) * 1996-07-04 1999-08-19 Epazon B V Gerät zur Bereitstellung eines Atemgases
ID21477A (id) 1997-03-26 1999-06-17 Janssen Pharmaceutica Nv Pelet-pelet yang mempunyai inti yang dilapisi dengan suatu anti jamur dan suatu polimer

Also Published As

Publication number Publication date
ES2157731A1 (es) 2001-08-16
JP4190732B2 (ja) 2008-12-03
HRP20010128B1 (en) 2003-12-31
PL345625A1 (en) 2002-01-02
DK1103252T3 (da) 2003-07-14
MEP26708A (en) 2010-06-10
HUP0103708A3 (en) 2002-07-29
KR100572135B1 (ko) 2006-04-19
EE04415B1 (et) 2005-02-15
NO20010289L (no) 2001-03-07
NO20010289D0 (no) 2001-01-17
AU750730B2 (en) 2002-07-25
IL140910A0 (en) 2002-02-10
ES2157731B1 (es) 2002-05-01
NZ509886A (en) 2002-09-27
BG105282A (en) 2001-11-30
DE69905905T2 (de) 2004-03-04
NO320054B1 (no) 2005-10-17
SK862001A3 (en) 2001-08-06
BR9912300A (pt) 2001-04-17
UA64009C2 (en) 2004-02-16
BG65187B1 (bg) 2007-06-29
CZ291938B6 (cs) 2003-06-18
ATE234077T1 (de) 2003-03-15
PT1103252E (pt) 2003-07-31
CA2337509C (en) 2005-12-27
ES2194480T3 (es) 2003-11-16
RU2209628C2 (ru) 2003-08-10
HU228895B1 (en) 2013-06-28
YU3901A (sh) 2003-08-29
RS50063B (sr) 2009-01-22
ZA200101293B (en) 2001-08-21
TR200100177T2 (tr) 2001-07-23
AU4782199A (en) 2000-02-14
HUP0103708A2 (hu) 2002-02-28
US6737082B1 (en) 2004-05-18
IL140910A (en) 2004-03-28
DE69905905D1 (de) 2003-04-17
MXPA01000681A (es) 2002-04-24
JP2002521323A (ja) 2002-07-16
EP1103252A1 (en) 2001-05-30
KR20010070990A (ko) 2001-07-28
PL194740B1 (pl) 2007-06-29
HRP20010128A2 (en) 2002-12-31
WO2000004881A1 (es) 2000-02-03
EP1103252B1 (en) 2003-03-12
EE200100041A (et) 2002-06-17
CZ2001175A3 (en) 2001-05-16
HK1037531A1 (en) 2002-02-15
CA2337509A1 (en) 2000-02-03

Similar Documents

Publication Publication Date Title
SK283279B6 (sk) Orálny farmaceutický prostriedok protihubovo účinnej zlúčeniny a spôsob jeho prípravy
EP1010423B1 (en) Oral pharmaceutical preparation comprising an antiulcer benzimidazole derivative, and process for its production
FI112437B (fi) Menetelmä antifungaalisella aineella ja polymeerilla päällystetyn ytimen käsittävien helmien valmistamiseksi
CA2290824A1 (en) Benzimidazole pharmaceutical composition and process of preparation
JP2004517064A (ja) 活性成分をベースとする微小顆粒およびその製造方法
PL194527B1 (pl) Powlekane cząsteczki krystalicznego ibuprofenu oraz sposób ich wytwarzania
MXPA00001087A (en) Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20140720